The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca Canada; BMS Brazil; MSD
Speakers' Bureau - BMS Brazil; MSD
Research Funding - BMS Brazil; Roche

A study of senaparib in combination with temozolomide for the treatment of patients with advanced solid tumors and extensive-stage small cell lung cancer.
 
Bo Gao
Consulting or Advisory Role - BeiGene; MSD
 
Chia-Chi Lin
Honoraria - Daiichi Sankyo; Lilly; Novartis; Novartis; Roche
Consulting or Advisory Role - Abbvie; Blueprint Medicines; Boehringer Ingelheim; Daiichi Sankyo; Novartis; PharmaEngine
Travel, Accommodations, Expenses - BeiGene; Daiichi Sankyo; Daiichi Sankyo; Lilly; Novartis
 
Li-Yuan Bai
Honoraria - CStone Pharmaceuticals; Ipsen; Lilly; Ono Pharmaceutical; Pfizer; SynCoreBio
Consulting or Advisory Role - Bristol-Myers Squibb; Zai Lab
Research Funding - Eisai
 
Wei-Pang Chung
Consulting or Advisory Role - Amgen; AstraZeneca Canada; Daiichi Sankyo; Everest Medicine; Lilly; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - Amgen; AstraZeneca Canada; Daiichi Sankyo; Everest Medicine; Lilly; MSD; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Amgen; AstraZeneca Canada; Pfizer; Roche
 
Wan-Chen Kao
No Relationships to Disclose
 
Robert Zielinski
No Relationships to Disclose
 
Byoung Yong Shim
Consulting or Advisory Role - Takeda
Research Funding - Yuhan
 
Min Hee Hong
Stock and Other Ownership Interests - GI biome; GI cell
Honoraria - AstraZeneca; AstraZeneca; Merck; Roche
Consulting or Advisory Role - AstraZeneca; Merck; Roche; Yuhan
Research Funding - Yuhan
 
Sang-We Kim
No Relationships to Disclose
 
Chien-Ying Liu
No Relationships to Disclose
 
Chih-Yi Hsieh
Employment - ASLAN Pharmaceuticals; IMPAC Medical Systems
Leadership - ASLAN Pharmaceuticals; IMPAC Medical Systems
Stock and Other Ownership Interests - ASLAN Pharmaceuticals; IMPAC Medical Systems
 
Sui Xiong Cai
Employment - IMPAC Medical Systems
Leadership - IMPAC Medical Systems
Stock and Other Ownership Interests - IMPAC Medical Systems
 
Ye Edward Tian
Employment - IMPAC Medical Systems
Leadership - IMPAC Medical Systems
Stock and Other Ownership Interests - IMPAC Medical Systems
Patents, Royalties, Other Intellectual Property - IMPAC Medical Systems
 
Lan Liu
Employment - IMPAC Medical Systems
 
Tiantian Niu
Employment - CSPC Pharmaceutical Group; IMPAC Medical Systems
 
Clare Halcro
Employment - Novotech; Sanofi
Stock and Other Ownership Interests - Crispr Therapeutics; Moderna Therapeutics; Sanofi
 
Baoyue Li
Employment - IMPAC Medical Systems
 
Ning Ma
Employment - IMPAC Medical Systems
Leadership - IMPAC Medical Systems
Stock and Other Ownership Interests - IMPAC Medical Systems
 
Congcong Zhang
Employment - IMPAC Medical Systems
Honoraria - IMPAC Medical Systems
Patents, Royalties, Other Intellectual Property - IMPAC Medical Systems (Inst)
Travel, Accommodations, Expenses - IMPAC Medical Systems
 
Xiangna Chen
Employment - IMPAC Medical Systems